Lay-Offs at J&J Pharma Won t Affect Existing Alliances; Not Many Genomic Positions Axed | GenomeWeb

NEW YORK, March 6 (GenomeWeb News) - Johnson & Johnson's decision to downsize its R&D program, disclosed last month, will not affect existing alliances, including genomic-related partnerships, the company said Friday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.